Stocktoria

Park Ha Biological Technology Co., Ltd. BYAH

Park Ha Biological Technology Co., Ltd. statistics & valuation

Profitability & efficiency

Net margin (%)
34.60% 20.10% -965.00% 202320242025
Gross margin (%)
87.40% 91.80% 94.40% 202320242025
Operating margin (%)
48.00% 33.30% -956.50% 202320242025
Return on equity (%)
84.20% 31.80% -609.90% 202320242025
Shares outstanding
25.0M 25.0M 588866 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
37.60% 15.50% -409.30% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
202320242025
EPS ($)
$1.70 $0.96 -$41.38 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin94.4%91.8%87.4%
Operating margin-956.5%33.3%48.0%
Net margin-965.0%20.1%34.6%
Return on assets-409.3%15.5%37.6%
Return on equity-609.9%31.8%84.2%
Current ratio2.921.871.75

Computed from company filings · US · as of 2025-10-31. Facts plus Stocktoria's own computed scores — not investment advice.